BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 13558713)

  • 1. The use of amodiaquin (camoquin) in the treatment of polymorphous light eruption.
    CAHN MM; LEVY EJ; SHAFFER B
    AMA Arch Derm; 1958 Aug; 78(2):245-6. PubMed ID: 13558713
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphous light eruption; a discussion of its pathogenesis and the therapeutic action of the antimalarials in this disease.
    SHAFFER B; CAHN MM; LEVY EJ
    J Invest Dermatol; 1959 Feb; 32(2, Part 2):363-6. PubMed ID: 13641811
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative study of chloroquine and amodiaquin in the treatment of giardiasis.
    LAMADRID-MONTEMAYOR F
    Am J Trop Med Hyg; 1954 Jul; 3(4):709-11. PubMed ID: 13180830
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of the antimalarial effects of suppressive doses of chloroquine, amodiaquin, and pyrimethamine.
    MILLER MJ
    Am J Trop Med Hyg; 1954 May; 3(3):458-63. PubMed ID: 13158765
    [No Abstract]   [Full Text] [Related]  

  • 5. Polymorphous light eruption; the effect of chloroquine phosphate in modifying reactions to ultra-violet light.
    CAHN MM; LEVY EJ; SHAFFER B
    J Invest Dermatol; 1956 Mar; 26(3):201-7. PubMed ID: 13319807
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentialities of monthly doses of camoquin and a gametocidal drug in malaria control.
    WALKER AJ
    Trans R Soc Trop Med Hyg; 1955 Jul; 49(4):351-5. PubMed ID: 13247347
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthetic antimalarial drugs in chronic discoid lupus erythematosus and light eruptions.
    ROGERS J; FINN OA
    AMA Arch Derm Syphilol; 1954 Jul; 70(1):61-6. PubMed ID: 13170820
    [No Abstract]   [Full Text] [Related]  

  • 8. Spectrophotometric and electrophoretic patterns of sera of patients with polymorphous light eruption.
    CAHN MM; LEVY EJ; VANDENBELT JM; SHAFFER B
    J Invest Dermatol; 1958 Aug; 31(2):93-4. PubMed ID: 13563951
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimalarials in the treatment of discoid lupus erythematosus; special reference to amodiaquin (camoquin).
    LEEPER RW; ALLENDE MF
    AMA Arch Derm; 1956 Jan; 73(1):50-7. PubMed ID: 13275124
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic trials with pyrimethamine (daraprim), resochin, amodiaquin (camoquin) and quinine.
    SRIVASTAVA JR
    Indian J Malariol; 1953 Dec; 7(4):347-50. PubMed ID: 13183650
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment on malaria with single doses of mepacrine, chloroquine and amodiaquin.
    BORODA C
    West Afr Med J; 1955 Sep; 4(3):144-8. PubMed ID: 13274779
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiarrhythmics. II. Amodiaquin (camoquin) in cardiac arrhythmias.
    ARORA RB; MADAN BR
    Indian J Med Res; 1956 Jan; 44(1):99-106. PubMed ID: 13306310
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of acute malaria with single oral doses of amodiaquin, chloroquine, hydroxychloroquine and pyrimethamine.
    HOEKENGA MT
    Am J Trop Med Hyg; 1954 Sep; 3(5):833-8. PubMed ID: 13197717
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the chemotherapy of malaria. IV. The treatment of acute malaria with amodiaquin (camoquin).
    EDESON JF; WILSON T; TURNER LH; LAING AB
    Med J Malaya; 1955 Jun; 9(4):252-9. PubMed ID: 13253124
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of amodiaquin hydrochloride (camoquin hydrochloride) against giardiasis.
    ROSENBERG J; NEUMANN E
    Am J Trop Med Hyg; 1957 Jul; 6(4):679-80. PubMed ID: 13458673
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the chemotherapy of malaria. V. The suppression of malaria by amodiaquin (camoquin).
    EDESON JF; TURNER LH; LAING AB
    Med J Malaya; 1955 Jun; 9(4):260-4. PubMed ID: 13253125
    [No Abstract]   [Full Text] [Related]  

  • 17. Amodiaquin (camoquin) in the treatment of chronic discoid lupus erythematosus; preliminary report, with special reference to the successful response of patients resistant to other antimalarial drugs.
    LOCKWOOD JH; PAPPENFORT RB
    AMA Arch Derm; 1956 Oct; 74(4):384-6. PubMed ID: 13361512
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative assessment of chloroquine and amodiaquine as malaria suppressives in Nigeria.
    CHARLES LJ
    Ann Trop Med Parasitol; 1958 Mar; 52(1):55-67. PubMed ID: 13521705
    [No Abstract]   [Full Text] [Related]  

  • 19. Polymorphous light eruption; some unusual reactions in ultraviolet light test sites.
    LEVY EJ; CAHN MM; SHAFFER B
    J Invest Dermatol; 1957 Feb; 28(2):147-52; discussion, 152-3. PubMed ID: 13416683
    [No Abstract]   [Full Text] [Related]  

  • 20. Unusual toxic manifestations to amodiaquin (camoquin).
    BLEIL DC
    AMA Arch Derm; 1958 Jan; 77(1):106-7. PubMed ID: 13486940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.